NIH and FDA researchers increasingly depend on data from an array of sources and they want to bring real-world evidence into their work. That includes the NIH’s All of Us precision medicine initiative.
More than 60 patient and medical research advocates are calling for a federal probe of two clinical trials at Minneapolis-based Hennepin County Medical Center that involved testing the anesthetic ketamine on patients without their consent.
For-profit chain HCA Healthcare’s net income jumped 25% during the second quarter of 2018, beating key earnings predictions from Wall Street analysts, according to its earnings release Wednesday.
The CMS issued a final rule to resume its risk-adjustment payments to insurance companies with plans on the individual market. The program is slated to shuffle $10 billion dollars for 2017.
A federal district judge said it’s possible the Trump administration’s new criteria for Title X family planning funding may not bar grants to Planned Parenthood, signaling he may reject the group’s second request to halt the formula changes.
Alabama and Illinois are the first states to take advantage of new flexibility to define the essential health benefits that certain insurers must provide. Their approaches show how some seek to bolster their ACA markets while others weaken them.
An addiction treatment representative urged House lawmakers to consider legislation to help stop patient-brokering fraud, but policymaking on the issue is complicated by states’ regulatory roles.